Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02381886
Title A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals

Advanced Solid Tumor

hematologic cancer



Age Groups: adult
Covered Countries USA | ESP | DEU | CAN | BEL

Additional content available in CKB BOOST